鏈夋病鏈夎汉鐫€灏辫兘鐦︾殑鑽紵涓€鏂囨礊鎮夋墍鏈夊噺鑲ヨ嵂

鍦ㄤ复搴婅瘯楠屼腑锛岃繖浜涜嵂鐗╅兘琛ㄧ幇鍑轰簡闈炲父濂界殑浣滅敤锛屼笌瀹夋叞鍓傜浉姣旓紝鎵€鏈夊鏂瑰噺鑲ヨ嵂鍧囪兘鏄捐憲鍑忚交浣撻噸銆傚湪闀胯揪12涓湀鐨勪娇鐢ㄨ繃绋嬩腑锛岃繖浜涜嵂鐗╄兘澶熶笉鍚岀▼搴﹀湴棰濆鍑忓幓浣撻噸鐨?锛呰嚦7锛咃紝鎵€浠ヨ姣旇捣鍗曠函閫氳繃鏀瑰彉鐢熸椿涔犳儻鈥斺€旀瘮濡傛帶鍒堕ギ椋熷拰瑙勫緥杩愬姩鈥斺€旀潵鍑忚偉锛屽悓姝ヤ娇鐢ㄨ繖浜涜嵂鐗╃殑纭兘澶熻鎮ｈ€呮洿蹇洿楂樻晥鍦拌揪鍒扮洰鏍囥€傜湅鍒拌繖閲岋紝涔熻澶у浼氳寰?锛呰嚦7锛呰繖涓暟瀛楃湅璧锋潵浼间箮骞朵笉鏄緢璧风溂锛屼絾鏄椤圭爺绌惰〃鏄庯紝鍑忓幓鎬讳綋閲嶇殑杩欓儴鍒嗘瘮渚嬪彲浠ュ甫鏉ョ殑鍋ュ悍鐩婂瓒呬箮棰勬枡锛屽寘鎷彲浠ラ檷浣庝汉浣撶殑琛€鍘嬨€佽绯栧拰鐢樻补涓夐吀閰按骞崇瓑绛夈€侟/p>

鍊煎緱寮鸿皟鐨勬槸锛岃繖浜涜嵂鐗╁苟涓嶆槸鐏典腹濡欒嵂锛屽拰鍏朵粬鑽墿涓€鏍峰瓨鍦ㄥ壇浣滅敤銆傚彟澶栵紝杩欎簺鍑忚偉鑽墿鐨勪娇鐢ㄥ墠鎻愰兘鏄厤鍚堟帶鍒堕ギ椋熷拰瑙勫緥杩愬姩銆傛病鏈夐殢闅忎究渚跨殑鎴愬姛锛屾病鏈変笉鍔宠€屽幓鐨勪綋閲嶏紝甯屾湜澶у璋ㄨ鍦ㄥ績銆侟/p>

4. How锛氳繖浜涜嵂鐗╂槸鎬庝箞甯姪浣犲噺鑲ョ殑鍛紵

澶у鏁板鏂瑰噺鑲ヨ嵂閮芥槸閫氳繃闈跺悜澶ц剳涓殑绁炵粡鍥炶矾鏉ユ姂鍒堕娆叉垨鑰呭鍔犻ケ鑵规劅鏉ヨ捣浣滅敤鐨勶紝姣斿Belviq閫氳繃婵€娲讳綅浜庝笅涓樿剳鐨勫ぇ鑴戝尯鍩熶腑鐨?-HT2C鍙椾綋锛堜竴绉?-缇熻壊鑳哄彈浣擄級鏉ラ檷浣庢偅鑰呯殑椋熸锛屼粠鑰岃揪鍒板府鍔╂偅鑰呮帶鍒朵綋閲嶇殑鐩殑銆傝櫧鐒朵笌Belviq浣滅敤鐨勯澏鐐逛笉鍚岋紝浣哘symia鍜孋ontrave閮芥槸閫氳繃杩欐牱鐨勬満鍒舵潵鍑忚交浣撻噸鐨勩€侟/p>

Saxenda鐨勪綔鐢ㄦ満鍒朵篃寰堟湁瓒ｏ紝瀹冧笌澶╃劧浜鸿儼楂樿绯栫礌鏍疯偨-1锛圙LP-1锛夌浉浼煎害杈?7%銆傚ぇ瀹跺彲鑳戒細瀵笹LP-1鎰熷埌濂藉銆傝儼楂樿绯栫礌鏍疯偨-1锛圙LP-1锛夋槸涓€绉嶄富瑕佺敱鑲犻亾L缁嗚優鎵€浜х敓鐨勬縺绱狅紝瀹冪殑鐢熺悊浣滅敤鏄績杩涜儼宀涚礌鍒嗘硨骞舵姂鍒惰儼楂樿绯栫礌鍒嗘硨锛岀粡鐢变腑鏋㈢缁忕郴缁燂紝瀹冭繕鍙互鎶戝埗椋熸銆傜敱浜嶨LP-1鐨勭壒娈婄敓鐞嗕綔鐢紝瀹冧篃鏄幇鍦ㄧ硸灏跨梾瀛﹂噷鐨勭儹闂ㄧ爺绌跺璞°€係axenda涓庝汉浣揋LP-1鐨勪綔鐢ㄦ満鍒剁被浼硷紝鍙互璋冭妭鑳冨彛锛屽苟閫氳繃鍑忓皯椋熺墿鎽勫叆鏉ラ檷浣庝綋閲嶃€傚畠涓昏鏄敤浜庢垚浜?鍨嬬硸灏跨梾鎮ｈ€呮帶鍒惰绯栵紝2014骞村畠鐨勬敞灏勫墏琚獸DA鎵瑰噯浣滀负楗鎺у埗鍜屼綋鑲查敾鐐肩殑琛ュ厖锛岀敤浜庢參鎬ц偉鑳栫殑娌荤枟锛屽畠涔熸槸鐢ㄤ簬鑲ヨ儢娌荤枟鐨勯娆炬棩鐢ㄤ竴娆＄殑浜鸿儼楂樿绯栫礌鏍疯偨-1锛圙LP-1锛 绫讳技鐗┿€備箣鍚庡悓鏍锋槸鐢辫鍜岃寰峰叕鍙革紙Novo Nordisk锛夋帹鍑虹殑semaglutide锛堢储椹瞾鑲斤級锛屼篃鏄€氳繃鐩稿悓鐨勬満鍒讹紝鏉ヨ揪鍒版帶鍒惰绯栦笌鍑忛噸鐨勬晥鏋滐紝鍦?017骞?2鏈堝垵锛屽畠浠ュ搧鐗屽悕Ozempic鑾峰緱FDA鎵瑰噯涓婂競锛屽湪姝ゅ氨涓嶈禈杩颁簡銆侟/p>

姣旇緝鐗规畩鐨勬槸鏈€鏃╀笂甯傜殑濂ュ埄鍙镐粬涓庢渶鏅氫笂甯傜殑Plenity锛屽ゥ鍒╁徃浠栦簬1999骞村湪缇庡浗琚壒鍑嗕笂甯傦紝瀹冩槸涓€绉嶉暱鏁堜笖寮烘晥鐨勭壒寮傛€ц儍鑲犻亾鑴傝偑閰舵姂鍒跺墏锛岄€氫織鏉ヨ锛屽ゥ鍒╁徃浠栨槸閫氳繃闃绘浜轰綋鎽勫叆鐨勮剛鑲鍚告敹杩欎竴杩囩▼鏉ヨ揪鍒板噺閲嶇殑鐩殑銆侟/p>

浠婂勾4鏈?5鏃ワ紝Gelesis鍏徃鐮斿彂鐨勭敤浜庢帶鍒朵綋閲嶇殑浜у搧Plenity涓婂競銆備笌浠ュ線鑾锋壒鐨勫噺鑲ヨ嵂浣滅敤鏈哄埗涓嶅悓锛孭lenity骞朵笉閫氳繃琛€娑茶繘鍏ュぇ鑴戣繘鑰屽彂鎸ヤ綔鐢紝鑰屽皢涓ょ澶╃劧鎴愬垎鈥斺€旀敼閫犺繃鐨勭氦缁寸礌鍜屾煚妾吀浜よ仈鍦ㄤ竴璧凤紝閫氳繃杩欑姘存憾鑳堕绮掕繘鍏ヨ儍閮ㄤ箣鍚庡惛姘村舰鎴愮殑涓夌淮缁撴瀯锛岃繀閫熻啫鑳€骞跺崰鎹?/4鐨勮儍瀹归噺锛屼粠鑰屽紩鍙戦ケ鑵规劅銆傚叾鏈韩璐ㄥ湴鍜屽拃鍤艰繃鐨勯鐗╃浉杩戜笖涓嶄細鎻愪緵鐑噺锛屽彲浠ュ府鍔╀汉浠帶鍒堕ギ椋熻繘鑰屽噺鑲ョ殑鐩殑銆侟/p>

5.浣跨敤鍑忚偉鑽簲璇ユ敞鎰忎竴浜涗粈涔堬紵

鈶 浣跨敤鍓嶆彁锛氶渶瑕佹敞鎰忕殑鏄繖浜涜嵂鐗╅兘鏄妭椋熷拰閿荤偧鐤楁硶鐨勮緟鍔╂不鐤楄嵂锛屼篃灏辨槸璇村湪浣跨敤杩欎簺鍑忚偉鑽墿鐨勫悓鏃堕兘闇€瑕侀厤鍚堟帶鍒堕ギ椋熷拰瑙勫緥杩愬姩锛岋紙ps锛氳繖宸茬粡鏄繖绡囨枃绔犲嚭鐜扮殑绗笁娆℃彁閱掍簡鍝︼紒锛堻/p>

鈶 鍑忚偉鑽渶瑕佷娇鐢ㄥ涔咃細鏈嶇敤鍑忚偉鑽殑鏃堕棿鍙栧喅浜庤嵂鐗╂槸鍚﹁捣鏁堜互鍙婃槸鍚︿骇鐢熶簡鍓綔鐢紝濡傛灉浣撻噸寰楀埌鍑忚交锛屽仴搴风姸鍐靛彉濂斤紝骞朵笖娌℃湁涓ラ噸鐨勫壇浣滅敤锛屽垯鍙互鍦ㄥ尰鐢熺殑鎸囧涓嬩竴鐩翠娇鐢ㄣ€傚鏋滃湪鎸夌収瑕佹眰鏈嶇敤鎵€闇€鍓傞噺鐨勮嵂鐗╃殑12鍛ㄥ悗锛屾湭鑳藉噺杞昏捣濮嬩綋閲嶇殑5锛咃紝鍖荤敓鍙兘浼氬缓璁仠姝㈡湇鐢紝鏇存敼娌荤枟璁″垝鎴栬€冭檻浣跨敤鍏朵粬鍑忚偉鑽€傜敱浜庤偉鑳栨槸涓€绉嶆參鎬х柧鐥咃紝杩欎釜杩囩▼鍙兘浼氭寔缁暟骞寸敋鑷充竴鐢燂紝鎸佷箣浠ユ亽鍦颁繚鎸佽壇濂界殑鐢熸椿涔犳儻锛屽寘鎷敼鍙橀ギ椋熷拰浣撹偛娲诲姩涔犳儻浠ユ敼鍠勫仴搴风姸鍐靛苟淇濇寔鍋ュ悍鐨勪綋閲嶃€侟/p>

鈶 鍏蜂綋姣忕鑽墿鐨勭蹇岀棁鍜屾敞鎰忎簨椤瑰彲浠ョ湅涓嬭〃锛欬/p>

鈶 鐩墠锛岄櫎浜嗗ゥ鍒╁徃浠栫殑灏忛噺鍓傚瀷鐗堟湰锛圓lli锛夊锛屽叾浠栫殑鍑犵鍑忚偉鑽潎涓哄鏂硅嵂锛屽垏璁颁笉瑕佽嚜涓昏喘涔板苟涓嶅綋浣跨敤锛岃涓€瀹氳鍦ㄥ尰鐢熺殑鎸囧涓嬶紝鎸夌収鍖诲槺浠ュ強浣跨敤璇存槑涔﹀Ε褰撲娇鐢紝褰撳嚭鐜颁弗閲嶄笉鑹弽搴旂瓑鐥囩姸鏃跺簲鍙婃椂灏卞尰锛岄噰鍙栨湁鏁堢殑椋庨櫓绠＄悊鎺柦鏈€澶ч檺搴﹀湴鍑忓皯涓嶈壇鍙嶅簲鐨勫彂鐢熴€侟/p>

鍐欏湪鏈€鍚嶞/p>

鑲ヨ儢鐥囧甫鏉ョ殑鍋ュ悍闂鏈夊緢澶氾紝浣嗘槸濂藉湪瀹冧滑鍦ㄥ緢澶х▼搴︿笂鏄彲棰勯槻鐨勩€傚湪瓒婃潵瓒婂鐨勪汉琚偉鑳栭棶棰樺洶鎵扮殑浠婂ぉ锛屸€滈槻鑳栦簬鏈劧鈥濇樉寰楅潪甯告湁蹇呰锛岃櫧鐒朵笂杩扮殑鑽墿鍧囪璇佸疄鏈夊緢濂界殑鎺у埗浣撻噸鐨勪綔鐢紝浣嗘棤涓€渚嬪鍦伴渶瑕侀厤鍚堢瀛﹂ギ椋熶範鎯拰瑙勫緥鍚堢悊鐨勮繍鍔ㄦ潵杈惧埌鍑忚偉鐨勭洰鐨勶紙绗簲娆℃彁鍒颁簡鏈嬪弸浠紒锛侊紒锛夈€侟/p>

鑲ヨ儢鍚屾椂涔熸槸涓€绉嶆參鎬х柧鐥咃紝鍑昏触瀹冩槸涓€涓极闀跨殑杩囩▼锛屽彲鑳介渶瑕佹寔缁暟骞寸敋鑷虫槸涓€鐢熺殑鍔姏锛屼篃瑕佹湁鍧氭寔涓嶆噲鐨勬亽蹇冦€傛渶鍚庣殑鏈€鍚庯紝杩樻槸瑕佹彁閱掑ぇ澶氭暟浜猴紝鍑忚偉鐨勯閫夌瓥鐣ヨ繕鏄鏀瑰彉鐢熸椿鏂瑰紡锛屽姞寮洪敾鐐煎苟涓旀敼鍠勯ギ椋燂紝璁╂憚鍏ョ殑鑳介噺灏忎簬娑堣€楃殑鑳介噺锛岃嚜鐒惰€岀劧灏变細鍙樺緱鍋ュ悍鍔ㄤ汉銆傛病鏈夐殢闅忎究渚跨殑鎴愬姛锛屾病鏈変笉鍔宠€屽幓鐨勪綋閲嶏紝涓轰簡鍋ュ悍锛岀湅鍒拌繖閲岀殑浣狅紝涓嶅姝ゅ埢灏辨斁涓嬫墜鏈猴紝璁╂垜浠竴璧疯鍔ㄨ捣鏉ャ€侟/p>

鍙傝€冩枃鐚?/p>

[1] World Health Organization. Obesity and Overweight. World Health Organization, Geneva, Switzerland, 2018. Available online: https://www.who.int/news-room/fact-sheets/detail/obesity- and-overweight

[2] Prescription weight-loss drugs:https://www.mayoclinic.org/healthy-lifestyle/weight-loss/in-depth/weight-loss-drugs/art-20044832

[3] Prescription Medications to Treat Overweight and Obesity: https://www.niddk.nih.gov/health-information/weight-management/prescription-medications-treat-overweight-obesity

[4] Yanovski, S. Z., & Yanovski, J. A. (2014). Long-term drug treatment for obesity: a systematic and clinical review. JAMA, 311(1), 74鈥?6. doi:10.1001/jama.2013.281361

[5] 鍊浗鍗?寮犵挓,閮戦鐢?涓浗鑲ヨ儢娴佽鐨勭幇鐘朵笌瓒嬪娍[J].涓浗椋熺墿涓庤惀鍏?2013,19(10):70-74.

[6] Montan, P. D., Sourlas, A., Olivero, J., Silverio, D., Guzman, E., & Kosmas, C. E. (2019). Pharmacologic therapy of obesity: mechanisms of action and cardiometabolic effects. Annals of translational medicine, 7(16), 393. doi:10.21037/atm.2019.07.27

[7] Heck, A. M., Yanovski, J. A., & Calis, K. A. (2000). Orlistat, a new lipase inhibitor for the management of obesity. Pharmacotherapy, 20(3), 270鈥?79. doi:10.1592/phco.20.4.270.34882

[8] Singh, J., & Kumar, R. (2015). Phentermine-topiramate: First combination drug for obesity. International journal of applied & basic medical research, 5(2), 157鈥?58. doi:10.4103/2229-516X.157177

[9] Lonneman, D. J., Jr, Rey, J. A., & McKee, B. D. (2013). Phentermine/Topiramate extended-release capsules (qsymia) for weight loss. P & T : a peer-reviewed journal for formulary management, 38(8), 446鈥?52.

[10] Gustafson, A., King, C., & Rey, J. A. (2013). Lorcaserin (Belviq): A Selective Serotonin 5-HT2C Agonist In the Treatment of Obesity. P & T : a peer-reviewed journal for formulary management, 38(9), 525鈥?34.

[11] Sherman, M. M., Ungureanu, S., & Rey, J. A. (2016). Naltrexone/Bupropion ER (Contrave): Newly Approved Treatment Option for Chronic Weight Management in Obese Adults. P & T : a peer-reviewed journal for formulary management, 41(3), 164鈥?72.

[12] Mehta, A., Marso, S. P., & Neeland, I. J. (2017). Liraglutide for weight management: a critical review of the evidence. Obesity science & practice, 3(1), 3鈥?4. doi:10.1002/osp4.84

[13] Gelesis Granted FDA Clearance to Market PLENITY? 鈥 a New Prescription Aid in Weight Management锛宭ink: https://www.businesswire.com/news/home/20190414005031/en/Gelesis-Granted-FDA-Clearance-Market-PLENITY?-鈥擖/p>

[14] Plenity Review: How It Works, Clinical Studies, Side Effects, and More 锛宭ink锛歨ttps://www.highya.com/plenity-reviews

鐗 鍒 鎻 绀裹/p>

鐗堟潈璇存槑锛氭杩庝釜浜鸿浆鍙戯紝浠讳綍褰㈠紡鐨勫獟浣撴垨鏈烘瀯鏈粡鎺堟潈锛屼笉寰楄浆杞藉拰鎽樼紪銆傝浆杞芥巿鏉冭鍦ㄣ€岃繑鏈淬€嶅叕浼楀彿鍐呰仈绯诲悗鍙般€侟/p>

銆婅繑鏈淬€嬶紝绉戝瀹堕鑸殑濂界鏅€傚浗闄呰憲鍚嶇墿鐞嗗瀹舵枃灏忓垰涓庣敓鐗╁瀹堕瀹佸叡鍚屽嚭浠绘€荤紪杈戯紝涓庢暟鍗佷綅涓嶅悓棰嗗煙涓€娴佸鑰呯粍鎴愮殑缂栧浼氫竴璧凤紝涓庝綘鍏卞悓姹傜储銆傚叧娉ㄣ€婅繑鏈淬€嬪弬涓庢洿澶氳璁恒€備簩娆¤浆杞芥垨鍚堜綔璇疯仈绯昏繑鏈村叕浼楀彿鍚庡彴銆侟/p>

经验内容仅供参考，如果您需解决具体问题(尤其法律、医学等领域)，建议您详细咨询相关领域专业人士。如需转载，请注明版权!

标题：鏈夋病鏈夎汉鐫€灏辫兘鐦︾殑鑽紵涓€鏂囨礊鎮夋墍鏈夊噺鑲ヨ嵂 网址：http://www.jrxk.cn/view/185393.html

发布媒体：好百科 作者：杩旀湸